Ctxr sec filings

WebBack to CTXR Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt... WebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report …

WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. WebMar 31, 2024 · Latest SEC filings for Citius Pharmaceuticals, Inc. (CTXR). Seeking Alpha - Go to Homepage Entering text into the input field will update the search … tt minority\u0027s https://marinchak.com

SEC.gov Filings & Forms - EDGAR

WebThis table shows the interest rate that must be paid by a short seller of US:CTXR to the lender of that security. This fee is shown as an annual percentage rate (APR). Lenders are funds or individuals that own the … WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebFind the latest SEC Filings data for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Citius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings … ttm initiated

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event …

Category:CTXR Institutional Ownership and Shareholders - Citius …

Tags:Ctxr sec filings

Ctxr sec filings

CTXR Short Interest Ratio and Volume (Citius Pharmaceuticals) …

WebFeb 8, 2024 · NASDAQ CTXR opened at $1.42 on Wednesday. Citius Pharmaceuticals, Inc. has a 12 month low of $0.77 and a 12 month high of $2.01. The firm has a market capitalization of $207.62 million, a PE ratio of -6.45 and a beta of 1.41. The company's 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.13. WebCTXR Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 88 Institutional Holders 15,192,898 Total Shares Held Back to CTXR Overview Institutional Holdings...

Ctxr sec filings

Did you know?

WebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials … WebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing.

WebCitius Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 04/08/2024 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider ... WebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter

WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Thu Dec 22 2024 Earnings Press Release 8-K Corporate News Citius Pharmaceuticals, Inc. …

WebMay 14, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 14 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

WebApr 6, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-018307 Submitted to the SEC: Wed Apr 06 2024 8:11:08 AM EST Accepted by the SEC: Wed Apr 06 2024 Period: Wednesday, April 6, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … phoenix in circleWebSep 28, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-059746 Submitted to the SEC: Wed Sep 28 2024 4:05:14 PM EST Accepted by the SEC: Wed Sep 28 2024 Period: Wednesday, September 28, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … ttm in oohcaWebJan 9, 2024 · Filings & Forms. All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. … ttm investmentsWebDec 17, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Mon Dec 16 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. ttm in medicalWebCommon stock, $0.001 par value CTXR The Nasdaq Capital Market  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ phoenix in chineseWebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024 phoenix in 1940WebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … ttm in telecom